BTK INHIBITOR COMPOUNDS

The invention provides BTK Inhibitor compounds, pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis. L'invention concerne des composés inhibiteurs de BTK, d...

Full description

Saved in:
Bibliographic Details
Main Authors KUKLISH, STEVEN LEE, QUIMBY, STEVEN JAMES, PARTRIDGE, KATHERINE MARIE, HENRY, KENNETH JAMES, KHILEVICH, ALBERT
Format Patent
LanguageEnglish
French
Published 09.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides BTK Inhibitor compounds, pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis. L'invention concerne des composés inhibiteurs de BTK, des sels pharmaceutiquement acceptables, des compositions pharmaceutiques de ceux-ci, et des procédés d'utilisation de ces composés, sels ou compositions pour traiter des maladies auto-immunes telles que la polyarthrite rhumatoïde.
Bibliography:Application Number: CA20183080123